Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells.
about
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular CarcinomaThe dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.Insulin-Like Growth Factor (IGF) System in Liver Diseases.PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines
P2860
Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@en
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@nl
type
label
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@en
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@nl
prefLabel
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@en
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@nl
P2093
P2860
P1433
P1476
Abnormal expression of insulin ...... mote apoptosis of tumor cells.
@en
P2093
Dengfu Yao
Ninghua Yao
Xiaodi Yan
Zhizhen Dong
P2860
P2888
P304
P356
10.1007/S13277-013-0912-Y
P577
2013-12-01T00:00:00Z